DIABETES CARE & DEVICES

Diabetes Care Device Pharmacist Recommendation & Brand Substitution Survey

Map how retail pharmacists evaluate, recommend, and substitute diabetes care devices across glucometers, CGMs, and insulin delivery systems, so you can sharpen brand positioning, fix substitution leakage, and convert recommendation intent into dispensing share.

Pan-India sample
Retail pharmacists (Dispensing Decision-Makers)
15-20 min
Talk to a Survey Consultant
Recommendation triggers & substitution momentsIdentify where pharmacists switch brands, override prescriptions, or recommend generics.
Brand preference & segment rankingBenchmark device brands by pharmacist preference across patient segment and price tier.
TRUSTED BY LEADING BRANDS
Brand 0Brand 1Brand 2Brand 3Brand 4Brand 5Brand 6Brand 7Brand 8Brand 9Brand 10Brand 11Brand 12Brand 13Brand 14Brand 15Brand 16Brand 17Brand 18Brand 19Brand 20Brand 21Brand 22Brand 23Brand 24Brand 25Brand 26Brand 27Brand 28Brand 29Brand 30Brand 31

CONTEXT & RELEVANCE

Why run this survey now

Most diabetes care device brands don't lose pharmacy shelf priority purely on clinical efficacy. They lose it due to pharmacist substitution habits, formulary gaps, patient price sensitivity, brand familiarity at the counter, and reimbursement friction, none of which fully show up in sell-in data or sales rep call reports.

If you are...

  • Device brand vs generic substitution
  • OTC diabetes portfolio head
  • Pharmacy channel trade lead
  • Reimbursement and access strategist
  • Commercial pricing review team

You're likely facing...

  • Brand switch at dispensing counter
  • Pharmacist loyalty: branded vs generic
  • Reimbursement gaps driving substitution
  • Patient price sensitivity vs compliance
  • Shelf placement vs recommendation disconnect

This will help answer...

  • Pharmacist recommendation drivers by brand
  • Substitution trigger stage and frequency
  • Segment preference: branded vs generic
  • Price threshold and margin tension
  • Loyalty barriers and switching triggers

RESEARCH THEMES

What This Survey Investigates

Eight interconnected research themes that map the complete pharmacist recommendation journey from device awareness to brand advocacy.

TENETS 01

Device Awareness

  • Brand recall at dispensing counter
  • Manufacturer rep visit frequency
TENETS 02

Recommendation Drivers

  • Clinical vs. commercial recommendation triggers
  • Prescriber alignment, patient affordability
TENETS 03

Substitution Behaviour

  • Branded-to-generic switch triggers
  • Out-of-stock substitution patterns
TENETS 04

Brand Perception

  • Accuracy trust, device reliability signals
  • Negative brand associations at counter
TENETS 05

Pricing & Margin

  • Trade margin thresholds by device category
  • Patient price sensitivity, reimbursement gaps
TENETS 06

Patient Counselling

  • Device onboarding time at counter
  • Adherence barriers, follow-up touchpoints
TENETS 07

Rep & Support

  • Medical rep visit quality, call frequency
  • Post-sale manufacturer support gaps
TENETS 08

Competitive Positioning

  • Share of shelf by device segment
  • Switching intent, loyalty thresholds

SAMPLING STRATEGY

Tell us about your ideal sample

Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.

Sample size
How many respondents do you need?
Not Selected
Target audience
Who should we survey?
Not Selected
Region
Which regions should we cover?
Not Selected
Segments
How should we slice the data?
Not Selected
Discuss sample plan

METHODOLOGY

Survey approach

For the Diabetes Care Device Pharmacist Recommendation and Brand Substitution Survey, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification across pharmacist cohorts.

PRIMARY
Online web surveySelf-administered survey shared via email / panels to capture structured responses at scale.
Best for
1
Ranking brand recommendation drivers by device category
2
Measuring substitution frequency across pharmacy formats
3
Comparing segments by chain, independent, and geography
Deliverables
Recommendation driver ranking
Substitution rate matrix
Brand preference scorecards
OPTIONAL
CATI (phone survey)Interviewer-led telephone interviews to reach owners who are harder to get online.
Best for
1
Independent pharmacists with low digital panel presence
2
Rapid coverage across Tier 2 and Tier 3 towns
Deliverables
Pharmacist coverage map
Call-log diagnostics
SELECTIVE
Face-to-faceOn-ground surveys or interviews in key industrial clusters or high-value cohorts.
Best for
1
High-volume diabetes specialty pharmacy counters
2
Pharmacists in hospital-adjacent or clinic-linked outlets
Deliverables
Counter-level insights
Dispensing behavior maps
OPTIONAL
FGDs
Deliverables
Themes and verbatims
Concept feedback
OPTIONAL
Mixed surveysAny 4-mode combo Online + CATI + F2F + FGDs to maximise reach and representation. Mode-specific quotas and weighting for clean comparisons.
Deliverables
Unified dataset
Mode-adjusted analytics
Our Recommendation
Start with: Online web survey as the core quant layer, targeting retail and chain pharmacists across urban and Tier 2 markets to capture recommendation and substitution patterns at scale.
Consider adding: CATI for independent pharmacists with low digital access, and F2F interviews at high-volume diabetes specialty counters where dispensing context requires on-ground verification.

EXECUTION PROCESS

How we execute

A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.

Define the decision frame

Confirm objectives, target cohorts, geographies, and reporting cuts

Step 01

Define the decision frame

Design the instrument

Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)

Step 02

Design the instrument

Lock the questionnaire

Review wording, sequencing, LOI, and competitive context; approve final version

Step 03

Lock the questionnaire

Pilot and calibrate

Test comprehension and ease quality; refine quotas and remove friction where needed

Step 04

Pilot and calibrate

Run fieldwork

Execute collection with active quota management and feasibility controls

Step 05

Run fieldwork

Assure quality

Dedupe, attention checks, speed/consistency rules, removals with audit trail

Step 06

Assure quality

Prepare the dataset

Clean data and deliver codebook/variable definitions

Step 07

Prepare the dataset

Analyse and synthesise

Driver ranking, leakage diagnostics, pricing bands, segment insights

Step 08

Analyse and synthesise

Deliver and align

Executive deck (optional dashboard) and leadership readout with recommendations

Step 09

Deliver and align

COMMERCIAL TERMS

Request a Commercial Proposal

Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.

Select Sample Size

100

Geography

  • India
  • APAC (Singapore, Vietnam, Philippines, Indonesia, Australia, NZ, Japan, Thailand)
  • Middle East (UAE, KSA, Qatar, Bahrain, Oman, Kuwait)
  • North America (US, Canada)
  • Europe
  • Africa (South Africa, Kenya, Nigeria, Egypt, Algeria)
  • LATAM (Brazil, Mexico)

Select Mode of Survey

  • Online
  • CATI
  • Online FGD (5 people per FGD)
  • F2F

Length of the Interview

  • Select
  • 0-15
  • 16-20
  • 21-30
  • 31-45
  • 46-60
  • Custom
Indicative Estimate
  • Indian Rupee (INR)
  • United Arab Emirates Dirham (AED)
  • Afghan Afghani (AFN)
  • Albanian Lek (ALL)
  • Armenian Dram (AMD)
  • Netherlands Antillean Guilder (ANG)
  • Angolan Kwanza (AOA)
  • Argentine Peso (ARS)
  • Australian Dollar (AUD)
  • Aruban Florin (AWG)
  • Azerbaijani Manat (AZN)
  • Bosnia-Herzegovina Convertible Mark (BAM)
  • Barbadian Dollar (BBD)
  • Bangladeshi Taka (BDT)
  • Bulgarian Lev (BGN)
  • Bahraini Dinar (BHD)
  • Burundian Franc (BIF)
  • Bermudian Dollar (BMD)
  • Brunei Dollar (BND)
  • Bolivian Boliviano (BOB)
  • Brazilian Real (BRL)
  • Bahamian Dollar (BSD)
  • Bhutanese Ngultrum (BTN)
  • Botswana Pula (BWP)
  • Belarusian Ruble (BYN)
  • Belize Dollar (BZD)
  • Canadian Dollar (CAD)
  • Congolese Franc (CDF)
  • Swiss Franc (CHF)
  • Chilean Peso (CLP)
  • Chinese Yuan (CNY)
  • Colombian Peso (COP)
  • Costa Rican Colón (CRC)
  • Cuban Peso (CUP)
  • Cape Verdean Escudo (CVE)
  • Czech Koruna (CZK)
  • Djiboutian Franc (DJF)
  • Danish Krone (DKK)
  • Dominican Peso (DOP)
  • Algerian Dinar (DZD)
  • Egyptian Pound (EGP)
  • Eritrean Nakfa (ERN)
  • Ethiopian Birr (ETB)
  • Euro (EUR)
  • Fijian Dollar (FJD)
  • Falkland Islands Pound (FKP)
  • British Pound (GBP)
  • Georgian Lari (GEL)
  • Ghanaian Cedi (GHS)
  • Gibraltar Pound (GIP)
  • Gambian Dalasi (GMD)
  • Guinean Franc (GNF)
  • Guatemalan Quetzal (GTQ)
  • Guyanese Dollar (GYD)
  • Hong Kong Dollar (HKD)
  • Honduran Lempira (HNL)
  • Croatian Kuna (HRK)
  • Haitian Gourde (HTG)
  • Hungarian Forint (HUF)
  • Indonesian Rupiah (IDR)
  • Israeli New Shekel (ILS)
  • Iraqi Dinar (IQD)
  • Iranian Rial (IRR)
  • Icelandic Króna (ISK)
  • Jamaican Dollar (JMD)
  • Jordanian Dinar (JOD)
  • Japanese Yen (JPY)
  • Kenyan Shilling (KES)
  • Kyrgyzstani Som (KGS)
  • Cambodian Riel (KHR)
  • Comorian Franc (KMF)
  • South Korean Won (KRW)
  • Kuwaiti Dinar (KWD)
  • Cayman Islands Dollar (KYD)
  • Kazakhstani Tenge (KZT)
  • Lao Kip (LAK)
  • Lebanese Pound (LBP)
  • Sri Lankan Rupee (LKR)
  • Liberian Dollar (LRD)
  • Lesotho Loti (LSL)
  • Libyan Dinar (LYD)
  • Moroccan Dirham (MAD)
  • Moldovan Leu (MDL)
  • Malagasy Ariary (MGA)
  • Macedonian Denar (MKD)
  • Burmese Kyat (MMK)
  • Mongolian Tögrög (MNT)
  • Macanese Pataca (MOP)
  • Mauritian Rupee (MUR)
  • Maldivian Rufiyaa (MVR)
  • Malawian Kwacha (MWK)
  • Mexican Peso (MXN)
  • Malaysian Ringgit (MYR)
  • Mozambican Metical (MZN)
  • Namibian Dollar (NAD)
  • Nigerian Naira (NGN)
  • Nicaraguan Córdoba (NIO)
  • Norwegian Krone (NOK)
  • Nepalese Rupee (NPR)
  • New Zealand Dollar (NZD)
  • Omani Rial (OMR)
  • Panamanian Balboa (PAB)
  • Peruvian Sol (PEN)
  • Papua New Guinean Kina (PGK)
  • Philippine Peso (PHP)
  • Pakistani Rupee (PKR)
  • Polish Złoty (PLN)
  • Paraguayan Guaraní (PYG)
  • Qatari Riyal (QAR)
  • Romanian Leu (RON)
  • Serbian Dinar (RSD)
  • Russian Ruble (RUB)
  • Rwandan Franc (RWF)
  • Saudi Riyal (SAR)
  • Solomon Islands Dollar (SBD)
  • Seychellois Rupee (SCR)
  • Sudanese Pound (SDG)
  • Swedish Krona (SEK)
  • Singapore Dollar (SGD)
  • Saint Helena Pound (SHP)
  • Sierra Leonean Leone (SLL)
  • Somali Shilling (SOS)
  • Surinamese Dollar (SRD)
  • São Tomé and Príncipe Dobra (STD)
  • Syrian Pound (SYP)
  • Swazi Lilangeni (SZL)
  • Thai Baht (THB)
  • Tajikistani Somoni (TJS)
  • Turkmenistani Manat (TMT)
  • Tunisian Dinar (TND)
  • Tongan Paʻanga (TOP)
  • Turkish Lira (TRY)
  • Trinidad and Tobago Dollar (TTD)
  • New Taiwan Dollar (TWD)
  • Tanzanian Shilling (TZS)
  • Ukrainian Hryvnia (UAH)
  • Ugandan Shilling (UGX)
  • United States Dollar (USD)
  • Uruguayan Peso (UYU)
  • Uzbekistani Som (UZS)
  • Vietnamese Đồng (VND)
  • Vanuatu Vatu (VUV)
  • Samoan Tālā (WST)
  • Central African CFA Franc (XAF)
  • East Caribbean Dollar (XCD)
  • West African CFA franc (XOF)
  • CFP Franc (XPF)
  • Yemeni Rial (YER)
  • South African Rand (ZAR)
  • Zambian Kwacha (ZMW)
  • Zimbabwean Dollar (ZWL)

$0.00

+ applicable taxes

Proposal turnaround typically 24–48 hours

Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.

REFERENCE CASELETS

Reference

Real-world examples of survey work in the diabetes care and pharmacy retail space.

CASELET 1

OTC glucose monitor channel preference & stocking behaviour (India)

CASELET 2

Insulin analogue substitution triggers & counselling behaviour (South India)

OTC glucose monitor channel preference & stocking behaviour (India)

OBJECTIVE

A mid-size medical device distributor needed to map how independent pharmacy owners and chain pharmacy managers prioritise stocking decisions for blood glucose monitors versus continuous glucose monitoring strips , and which brand attributes drove forward placement.

WHAT WE DID

Ran a structured quant survey across 320 pharmacy outlets in 6 metros and Tier 2 cities, capturing stocking frequency, reorder triggers, margin thresholds, brand recall rank, and the role of distributor incentives in shelf allocation decisions.

DELIVERED

A segment-level stocking preference map by outlet type, a ranked brand attribute corridor showing which device features drove forward placement, and a distributor incentive lever list by city tier and outlet format.
CASELET 1

OTC glucose monitor channel preference & stocking behaviour (India)

CASELET 2

Insulin analogue substitution triggers & counselling behaviour (South India)

OTC glucose monitor channel preference & stocking behaviour (India)

OBJECTIVE

A mid-size medical device distributor needed to map how independent pharmacy owners and chain pharmacy managers prioritise stocking decisions for blood glucose monitors versus continuous glucose monitoring strips , and which brand attributes drove forward placement.

WHAT WE DID

Ran a structured quant survey across 320 pharmacy outlets in 6 metros and Tier 2 cities, capturing stocking frequency, reorder triggers, margin thresholds, brand recall rank, and the role of distributor incentives in shelf allocation decisions.

DELIVERED

A segment-level stocking preference map by outlet type, a ranked brand attribute corridor showing which device features drove forward placement, and a distributor incentive lever list by city tier and outlet format.

FREQUENTLY ASKED QUESTIONS

Common Questions

Answers to frequently asked questions about this survey mandate.

What decisions will this survey enable?

Who is the buyer vs who are the respondents?

Can we see differences between independent pharmacy owners, chain pharmacy staff and hospital pharmacy dispensers?

How will you measure brand recommendation preference beyond simple ratings?

Will the survey map the full brand substitution journey and drop-offs?

Can this survey inform product and pricing strategy?

How will findings improve our pharmacy channel sales and trade marketing execution?

Still have questions?

Schedule a discovery call to discuss your specific needs and get a custom quote.

Book a Discovery Call